We are a bioengineering research group at the University of Oregon’s Knight Campus for Accelerating Scientific Impact.
We welcome new lab members from all backgrounds and recruit through a variety of science and engineering graduate and undergraduate programs at the University of Oregon.
We combine expertise in chemical and biomedical engineering to design biomaterials to control protein delivery to injured tissues.
We are grateful for funding from the Collins Medical Trust, OHSU Medical Research Foundation, National Institutes of Health, and Wu Tsai Human Performance Alliance.
Our research neighborhood is featured on the Knight Campus website for recent NIH grants awarded to our lab, the Plesa lab, and the Hosseinzadeh lab.
Congratulations to Henry Hochstatter for winning an Undergraduate Research Opportunity Program Mini-grant and to Yan Carlos Pacheco for winning the Knight Campus Diversity Award!
Several lab members won awards for their presentations at the Oregon Bioengineering Symposium! Congratulations to John O’Hara-Smith (1st place, flash talk), Ireland John (2nd place, flash talk), and Henry Hochstatter (1st place, undergraduate poster)!
The lab receives an R21 Trailblazer Award from the National Institute of Biomedical Imaging and Bioengineering! This $602,000, 3-year award will fund the lab’s work in using directed evolution to identify novel binding partners for affinity-controlled protein release.
The Knight Campus receives a second $500 million gift from Phil and Penny Knight! See more details and the video of the official announcement here.
Congratulations to Henry Hochstatter for winning a UO SPUR summer fellowship!
Ireland Johnson is featured on the Knight Campus website as a Maybelle Clark Macdonald Scholar!
The Hettiaratchi lab receives a Medical Research Foundation New Investigator Award to develop angiogenic biomaterials!
We published our first review paper, led by graduate student Jonathan Dorogin, in the 2021 Emerging Investigators issue of Biomaterials Science.